Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (351-360 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapyBaptiste Le Calvez, Marion Eveillard, Paul Decamps, et al.
Ejhaem|July 18, 2022
Clinical features and outcomes of duodenal-type follicular lymphoma: A single-center retrospective studyKimimori Kamijo, Yoshimitsu Shimomura, Satoshi Yoshioka, et al.
Ejhaem|July 18, 2022
Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: A single institution's experienceHiromichi Takahashi, Haruna Nishimaki, Yoko Nakanishi, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Ejhaem|July 18, 2022
GDF-15 is associated with atherosclerosis in adults with transfusion-dependent beta-thalassemiaAlaa Efat, Rana Wahb, Sabry Abd Allah Shoeib, et al.
Ejhaem|July 18, 2022
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.
Ejhaem|July 18, 2022
Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case seriesLeila Motedayen Aval, Mary Boullier, Hermione Lyall, et al.
Ejhaem|July 18, 2022
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial)Heinz Ludwig, Bela Hausmann, Martin Schreder, et al.
Ejhaem|July 18, 2022
High serum ferritin alone as a predictor of mortality and hemophagocytic lymphohistiocytosisShruti Kohli, Ritu Chadha, Neha Rastogi, et al.
Ejhaem|July 18, 2022
Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case reportSocorro María Rodríguez-Pinilla, Rocío Nieves Salgado, Cristina Chamizo, et al.
Pageof 93

Showing results (351-360 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapyBaptiste Le Calvez, Marion Eveillard, Paul Decamps, et al.
Ejhaem|July 18, 2022
Clinical features and outcomes of duodenal-type follicular lymphoma: A single-center retrospective studyKimimori Kamijo, Yoshimitsu Shimomura, Satoshi Yoshioka, et al.
Ejhaem|July 18, 2022
Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: A single institution's experienceHiromichi Takahashi, Haruna Nishimaki, Yoko Nakanishi, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Ejhaem|July 18, 2022
GDF-15 is associated with atherosclerosis in adults with transfusion-dependent beta-thalassemiaAlaa Efat, Rana Wahb, Sabry Abd Allah Shoeib, et al.
Ejhaem|July 18, 2022
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.
Ejhaem|July 18, 2022
Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case seriesLeila Motedayen Aval, Mary Boullier, Hermione Lyall, et al.
Ejhaem|July 18, 2022
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial)Heinz Ludwig, Bela Hausmann, Martin Schreder, et al.
Ejhaem|July 18, 2022
High serum ferritin alone as a predictor of mortality and hemophagocytic lymphohistiocytosisShruti Kohli, Ritu Chadha, Neha Rastogi, et al.
Ejhaem|July 18, 2022
Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case reportSocorro María Rodríguez-Pinilla, Rocío Nieves Salgado, Cristina Chamizo, et al.
Pageof 93